← brief for 2026-10-02 · Slowing decline
Soluble guanylate cyclase modulation in heart failure and chronic kidney disease: mechanisms, clinical evidence, and translational boundaries
Key takeaways
This review looks at how a specific drug target works in people with heart and kidney disease. It explains the biology behind these conditions and how they affect each other. The article discusses existing evidence but does not report new trial results. It helps readers understand the science behind potential treatments.
Who did this work
Wenhui Yuan (People's Hospital of Bishan District) · Bo Zhou (People's Hospital of Bishan District) · Changqing Yu (People's Hospital of Bishan District)
Source
Article · OpenAlex, CKD works · 2026-10-01
https://doi.org/10.3389/fphar.2026.1954549